Exact and LabCorp Expand CRC and Stool-Based DNA Alliance | GenomeWeb
NEW YORK (GenomeWeb News) — Exact Sciences today said that Laboratory Corporation of America has extended a license to distribute the company’s PreGen-Plus colorectal cancer screening test.
 
Under the expanded deal, LabCorp can now exclusively license the test through 2010, and Exact gets the right to license the technology to “select organizations and other commercial service laboratories.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.